ProSeed Venture Capital Fund

Correlsense is a developer of application performance management software that aids businesses in achieving IT reliability by monitoring and managing application performance. Founded in 2005 and privately held, Correlsense's flagship product, SharePath, provides comprehensive visibility into data center operations by tracking every transaction as it moves through the system. This capability allows businesses to quickly identify and resolve issues related to application performance, including crashes and slowdowns. SharePath is designed for ease of deployment and maintenance, making it suitable for organizations of all sizes. The software enhances the end-user experience, mitigates risks associated with new service rollouts and data center migrations, facilitates chargebacks for IT resources, and improves capacity planning. Additionally, Correlsense offers an Express edition of SharePath, which is a free enterprise-class software tool that measures the end-user experience for both cloud-based and on-premise applications.

EarlySense Ltd. is a developer of advanced patient monitoring systems tailored for hospitals, healthcare systems, integrated delivery networks, and rehabilitation centers. Founded in 2004 and based in Ramat Gan, Israel, with additional offices in Woburn, Massachusetts, the company specializes in signal-processing technology that enhances patient safety and facilitates early detection of health deterioration. Its flagship product, the EarlySense System, offers continuous monitoring of heart rate, respiratory rate, and patient motion, allowing clinical teams to manage risks such as falls and pressure ulcers. Additionally, the Central Display Station enables nursing staff to supervise patients effectively, while the contact-free consumer health monitor, known as LIVE, provides users and caregivers with insights into heart health, breathing cycles, and sleep quality. The company's offerings, including EarlySense Live, cater to a variety of healthcare environments and are distributed in Israel, the United States, and Australia. EarlySense has established a strategic partnership with Welch Allyn to further enhance its product capabilities.

Correlsense is a developer of application performance management software that aids businesses in achieving IT reliability by monitoring and managing application performance. Founded in 2005 and privately held, Correlsense's flagship product, SharePath, provides comprehensive visibility into data center operations by tracking every transaction as it moves through the system. This capability allows businesses to quickly identify and resolve issues related to application performance, including crashes and slowdowns. SharePath is designed for ease of deployment and maintenance, making it suitable for organizations of all sizes. The software enhances the end-user experience, mitigates risks associated with new service rollouts and data center migrations, facilitates chargebacks for IT resources, and improves capacity planning. Additionally, Correlsense offers an Express edition of SharePath, which is a free enterprise-class software tool that measures the end-user experience for both cloud-based and on-premise applications.

EarlySense Ltd. is a developer of advanced patient monitoring systems tailored for hospitals, healthcare systems, integrated delivery networks, and rehabilitation centers. Founded in 2004 and based in Ramat Gan, Israel, with additional offices in Woburn, Massachusetts, the company specializes in signal-processing technology that enhances patient safety and facilitates early detection of health deterioration. Its flagship product, the EarlySense System, offers continuous monitoring of heart rate, respiratory rate, and patient motion, allowing clinical teams to manage risks such as falls and pressure ulcers. Additionally, the Central Display Station enables nursing staff to supervise patients effectively, while the contact-free consumer health monitor, known as LIVE, provides users and caregivers with insights into heart health, breathing cycles, and sleep quality. The company's offerings, including EarlySense Live, cater to a variety of healthcare environments and are distributed in Israel, the United States, and Australia. EarlySense has established a strategic partnership with Welch Allyn to further enhance its product capabilities.

DigiFlex Ltd. is a manufacturer of innovative inkjet printing systems, specializing in the production of photopolymer flexographic, letterpress, dry-offset, and rotary silk screen printing plates. Established in 2005 and based in Kefar Sava, Israel, the company offers an inkjet-based computer-to-plate (CtP) solution that enhances the quality of analog printing plates while streamlining the production process. DigiFlex’s technology eliminates the need for traditional film and chemical processing, allowing users to manage the entire plate-making process in-house. This capability not only improves efficiency but also reduces costs for narrow web application printers. DigiFlex’s products are distributed across Europe, North America, the Far East, and other international markets. As of late 2017, DigiFlex operates as a subsidiary of P.V. Nano Cell Ltd.

Vigilance Networks is a security intelligence company that offers organizations with real-time IP communication solutions. Vigilance Networks provides real-time threat, fraud, and security intelligence for IP networks. Vigilance Networks was founded in 2009 by Jonathan Golovin and is based in Petah Tikva, Israel.

DigiFlex Ltd. is a manufacturer of innovative inkjet printing systems, specializing in the production of photopolymer flexographic, letterpress, dry-offset, and rotary silk screen printing plates. Established in 2005 and based in Kefar Sava, Israel, the company offers an inkjet-based computer-to-plate (CtP) solution that enhances the quality of analog printing plates while streamlining the production process. DigiFlex’s technology eliminates the need for traditional film and chemical processing, allowing users to manage the entire plate-making process in-house. This capability not only improves efficiency but also reduces costs for narrow web application printers. DigiFlex’s products are distributed across Europe, North America, the Far East, and other international markets. As of late 2017, DigiFlex operates as a subsidiary of P.V. Nano Cell Ltd.

Correlsense is a developer of application performance management software that aids businesses in achieving IT reliability by monitoring and managing application performance. Founded in 2005 and privately held, Correlsense's flagship product, SharePath, provides comprehensive visibility into data center operations by tracking every transaction as it moves through the system. This capability allows businesses to quickly identify and resolve issues related to application performance, including crashes and slowdowns. SharePath is designed for ease of deployment and maintenance, making it suitable for organizations of all sizes. The software enhances the end-user experience, mitigates risks associated with new service rollouts and data center migrations, facilitates chargebacks for IT resources, and improves capacity planning. Additionally, Correlsense offers an Express edition of SharePath, which is a free enterprise-class software tool that measures the end-user experience for both cloud-based and on-premise applications.

Correlsense is a developer of application performance management software that aids businesses in achieving IT reliability by monitoring and managing application performance. Founded in 2005 and privately held, Correlsense's flagship product, SharePath, provides comprehensive visibility into data center operations by tracking every transaction as it moves through the system. This capability allows businesses to quickly identify and resolve issues related to application performance, including crashes and slowdowns. SharePath is designed for ease of deployment and maintenance, making it suitable for organizations of all sizes. The software enhances the end-user experience, mitigates risks associated with new service rollouts and data center migrations, facilitates chargebacks for IT resources, and improves capacity planning. Additionally, Correlsense offers an Express edition of SharePath, which is a free enterprise-class software tool that measures the end-user experience for both cloud-based and on-premise applications.

Correlsense is a developer of application performance management software that aids businesses in achieving IT reliability by monitoring and managing application performance. Founded in 2005 and privately held, Correlsense's flagship product, SharePath, provides comprehensive visibility into data center operations by tracking every transaction as it moves through the system. This capability allows businesses to quickly identify and resolve issues related to application performance, including crashes and slowdowns. SharePath is designed for ease of deployment and maintenance, making it suitable for organizations of all sizes. The software enhances the end-user experience, mitigates risks associated with new service rollouts and data center migrations, facilitates chargebacks for IT resources, and improves capacity planning. Additionally, Correlsense offers an Express edition of SharePath, which is a free enterprise-class software tool that measures the end-user experience for both cloud-based and on-premise applications.

DigiFlex Ltd. is a manufacturer of innovative inkjet printing systems, specializing in the production of photopolymer flexographic, letterpress, dry-offset, and rotary silk screen printing plates. Established in 2005 and based in Kefar Sava, Israel, the company offers an inkjet-based computer-to-plate (CtP) solution that enhances the quality of analog printing plates while streamlining the production process. DigiFlex’s technology eliminates the need for traditional film and chemical processing, allowing users to manage the entire plate-making process in-house. This capability not only improves efficiency but also reduces costs for narrow web application printers. DigiFlex’s products are distributed across Europe, North America, the Far East, and other international markets. As of late 2017, DigiFlex operates as a subsidiary of P.V. Nano Cell Ltd.

Tehuti Networks Ltd. is a fabless semiconductor company based in Herzliya, Israel, founded in 2003. The company specializes in the development of Ethernet network traffic accelerators and Ethernet controllers, focusing on enhancing performance while maintaining low power consumption. Tehuti's products are designed to support high-volume applications in enterprise data centers, IP video servers, and various server platforms, enabling the adoption of 10 Gigabit Ethernet technology. Their 10GbE controllers operate in a partial offload mode, facilitating easier integration and optimized performance for clients requiring multi-gigabit Ethernet connectivity. Tehuti Networks has received support from the Technion R&D Fund to advance its TCP/IP acceleration technology and has attracted investments from several venture capital firms.

Vayar Vision Ltd. is a technology company based in Haifa, Israel, established in 2007. It specializes in developing a visual search engine that enhances the search capabilities of textual search engines and enables users to find information through images. The company's technology allows users to search large databases and the web for similar images, facilitating access to relevant visual content. Vayar's solutions cater to various sectors, providing tools for image banks with copyright protection, supporting homeland security and law enforcement in crowd analysis, and assisting in medical diagnostics by matching imaging data with medical literature. Additionally, Vayar integrates its visual search results with decision support systems, enhancing the way users discover and interact with visual information. The company aims to bridge the gap between images and textual information, creating a more intuitive search experience.

Regentis Biomaterials Ltd. is a company specializing in tissue repair, particularly in the development and commercialization of biodegradable hydrogels for repairing damaged cartilage tissue. Founded in 2004 and based in Or-Akiva, Israel, with an additional office in Princeton, New Jersey, the company’s core technology includes Gelrin, a hydrogel matrix composed of polyethylene glycol diacrylate and denatured fibrinogen. This innovative platform merges the stability of synthetic materials with the bio-functionality of natural substances, catering to various clinical applications. Regentis's flagship product, GelrinC, is designed for treating articular cartilage lesions and is currently undergoing clinical trials. The company’s focus is on orthopedic treatments, aiming to restore health and improve the quality of life for patients suffering from cartilage damage and related conditions.

APProtect Ltd. provides anti-piracy protection solutions for consumer and business software developers and publishers. It offers Trusted Server Protection products to protect CAD tools and scientific applications in companies, universities, and other organizations; Online Software Protector family of products for protecting consumer software; and splitting machine software, which operates on a binary and splits it into two parts. The company also provides splitting, site installation, and server hosting services. APProtect Ltd. was founded in 2004 and is based in Haifa, Israel.

Tehuti Networks Ltd. is a fabless semiconductor company based in Herzliya, Israel, founded in 2003. The company specializes in the development of Ethernet network traffic accelerators and Ethernet controllers, focusing on enhancing performance while maintaining low power consumption. Tehuti's products are designed to support high-volume applications in enterprise data centers, IP video servers, and various server platforms, enabling the adoption of 10 Gigabit Ethernet technology. Their 10GbE controllers operate in a partial offload mode, facilitating easier integration and optimized performance for clients requiring multi-gigabit Ethernet connectivity. Tehuti Networks has received support from the Technion R&D Fund to advance its TCP/IP acceleration technology and has attracted investments from several venture capital firms.

Mazor Robotics, founded in 2001 and headquartered in Caesarea, Israel, specializes in developing, producing, and marketing medical devices for orthopedic and neurosurgical procedures. The company's primary focus is on surgical robotic-guidance systems that enhance precision and minimize invasiveness during complex surgeries. Their flagship products include the Mazor X and Renaissance systems, which are used extensively in spine surgeries such as fusion, correction of spinal deformities, biopsy collection, tumor excision, and cement augmentations. These systems aim to provide a safer surgical environment for patients, surgeons, and operating room staff by transforming traditional freehand procedures into highly accurate, state-of-the-art operations with better clinical outcomes.

DiskSites is a company that specializes in developing network optimization solutions aimed at enterprises. Founded in 1999 by Divon Lan and Yuval Hager, and based in Tenafly, New Jersey, DiskSites offers wide area file services (WAFS) that facilitate access to centralized data for users at geographically distributed and remote offices. The company's solutions allow enterprises to effectively manage a file system designed to store and secure critical information. DiskSites has served a diverse clientele, including Fortune 2000 companies, governmental agencies, and educational institutions. In May 2006, DiskSites was acquired by Expand Networks.

GeneGrafts Ltd., also known as GreenGrafts Ltd., is a biotechnology company based in Haifa, Israel, specializing in the development of therapeutic products aimed at treating conditions such as cardiac arrhythmia, Parkinson's disease, and epilepsy. Founded in November 2003, the company has established a proprietary technology platform that employs cell therapy to modulate excitable tissues in the brain and heart. This innovative approach involves the transplantation of cell grafts derived from the patient's own body, which define the ion channels necessary for integrating with the target organ. By doing so, GeneGrafts seeks to alter the electrical properties of these organs in a controlled manner, providing a promising new avenue for the treatment of various neurological disorders and cardiac conditions.

Actito specializes in developing relationship marketing software designed to enhance personalized and one-to-one marketing strategies. Its comprehensive suite includes tools for customer life-cycle marketing, facilitating acquisition, loyalty, and cross-selling initiatives. The platform features a user-friendly interface that allows for the customization of various marketing applications through its Relationship Marketing Portal. Actito primarily serves large and medium-sized enterprises across diverse sectors, including automotive, finance, entertainment, and healthcare, enabling agile marketers to effectively define and execute their campaign objectives.